MoneyWorks4Me

Balaxi Pharma. - Quaterly Results

10 Feb 2025 Evaluate
A decrease in the sales to Rs. 111.58 millions was observed for the quarter ended December 2024. The sales stood at Rs. 127.00 millions during the similar quarter previous year.The Total revenue for the quarter ended December 2024 of  Rs. 17.43  millions  grew by 257.17% from Rs. 4.88 millions.The company reported a good operating profit of 30.14 millions compared to 13.09 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 111.58 127.00 -12.14 513.39 542.92 -5.44 701.96 1081.38 -35.09
Other Income 29.17 10.30 183.20 50.53 23.09 118.84 23.99 66.04 -63.67
PBIDT 30.14 13.09 130.25 81.39 72.71 11.94 76.35 234.26 -67.41
Interest 5.66 4.11 37.71 13.69 10.31 32.78 15.41 4.59 235.73
PBDT 24.48 8.98 172.61 67.70 62.40 8.49 60.94 229.67 -73.47
Depreciation 1.14 1.32 -13.64 3.45 3.95 -12.66 5.11 5.15 -0.78
PBT 23.34 7.66 204.70 64.25 58.45 9.92 55.83 224.52 -75.13
TAX 5.91 2.78 112.59 16.45 16.21 1.48 19.33 62.29 -68.97
Deferred Tax -0.19 -0.27 -29.63 -0.57 -0.33 72.73 -1.05 10.62 -109.89
PAT 17.43 4.88 257.17 47.80 42.24 13.16 36.50 162.23 -77.50
Equity 110.42 102.30 7.94 110.42 102.30 7.94 108.98 101.81 7.04
PBIDTM(%) 27.01 10.31 162.07 15.85 13.39 18.38 10.88 21.66 -49.79
Peers